0001450708
2014-11-01
2015-07-31
0001450708
2015-07-31
0001450708
2013-10-31
0001450708
us-gaap:CorporateJointVentureMember
aurm:CenturyConcessionMember
2014-11-01
2015-07-31
0001450708
us-gaap:PrincipalOwnerMember
2015-07-31
0001450708
us-gaap:CorporateJointVentureMember
aurm:CenturyConcessionMember
2010-12-31
0001450708
us-gaap:PrincipalOwnerMember
2009-07-31
0001450708
aurm:AxisConsultantsPtyLtdMember
2014-11-01
2015-07-31
0001450708
aurm:AxisConsultantsPtyLtdMember
2015-07-31
0001450708
aurm:ManagerOfLaosOperationsMember
2015-07-31
0001450708
country:US
2015-07-31
0001450708
us-gaap:CommonStockMember
aurm:FounderMember
us-gaap:PrivatePlacementMember
2008-09-01
2008-09-30
0001450708
us-gaap:CommonStockMember
aurm:PublicOfferingMember
2009-03-01
2009-03-31
0001450708
us-gaap:CommonStockMember
2014-11-01
2015-07-31
0001450708
aurm:GrantsIn2010Member
aurm:EquityIncentivePlan2010Member
2010-12-12
2010-12-13
0001450708
aurm:GrantsIn2011Member
aurm:EquityIncentivePlan2010Member
2011-05-02
2011-05-31
0001450708
aurm:GrantsIn2010Member
aurm:EquityIncentivePlan2010Member
2014-11-01
2015-07-31
0001450708
aurm:GrantsIn2011Member
aurm:EquityIncentivePlan2010Member
2014-11-01
2015-07-31
0001450708
aurm:GrantsIn2010Member
aurm:EquityIncentivePlan2010Member
2015-07-31
0001450708
aurm:GrantsIn2011Member
aurm:EquityIncentivePlan2010Member
2015-07-31
0001450708
us-gaap:CommonStockMember
2015-07-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2014-11-01
2015-07-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2015-07-31
0001450708
2017-09-22
0001450708
us-gaap:RetainedEarningsMember
2014-11-01
2015-07-31
0001450708
us-gaap:RetainedEarningsMember
2015-07-31
0001450708
2014-10-31
0001450708
2013-11-01
2014-07-31
0001450708
aurm:AxisConsultantsPtyLtdMember
2014-10-31
0001450708
aurm:ManagerOfLaosOperationsMember
2014-01-31
0001450708
us-gaap:MinimumMember
2014-11-01
2015-07-31
0001450708
us-gaap:MaximumMember
2014-11-01
2015-07-31
0001450708
aurm:GrantsIn2010Member
aurm:EquityIncentivePlan2010Member
2014-10-31
0001450708
us-gaap:EmployeeStockOptionMember
2014-11-01
2015-07-31
0001450708
us-gaap:CommonStockMember
2014-10-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2014-10-31
0001450708
us-gaap:RetainedEarningsMember
2014-10-31
0001450708
us-gaap:SubsequentEventMember
us-gaap:CommonStockMember
2016-04-02
2016-04-30
0001450708
us-gaap:SubsequentEventMember
aurm:MedicalTechnologyBusinessMember
us-gaap:ScenarioForecastMember
us-gaap:MaximumMember
2017-07-18
2017-07-19
0001450708
us-gaap:SubsequentEventMember
aurm:MedicalTechnologyBusinessMember
us-gaap:ScenarioForecastMember
2017-07-18
2017-07-19
0001450708
us-gaap:SubsequentEventMember
aurm:MedicalTechnologyBusinessMember
us-gaap:ScenarioForecastMember
2017-07-19
0001450708
us-gaap:SubsequentEventMember
us-gaap:CommonStockMember
2017-07-01
2017-07-31
0001450708
us-gaap:SubsequentEventMember
aurm:PayItSimpleMember
2016-04-01
0001450708
us-gaap:SubsequentEventMember
aurm:PayItSimpleMember
aurm:AdditionalEquityMethodInvestmentMember
2016-04-01
0001450708
us-gaap:SubsequentEventMember
aurm:PayItSimpleMember
2016-04-02
2016-04-30
0001450708
us-gaap:SubsequentEventMember
aurm:PayItSimpleMember
aurm:InterestHoldingPercentageMember
2016-04-01
0001450708
us-gaap:SubsequentEventMember
aurm:HumavoxMember
2016-06-27
0001450708
us-gaap:SubsequentEventMember
aurm:HumavoxMember
2016-06-01
2016-06-27
0001450708
us-gaap:SubsequentEventMember
aurm:HumavoxMember
2016-07-01
2016-07-31
0001450708
us-gaap:SubsequentEventMember
aurm:HumavoxMember
aurm:WarrantsAndOptionsMember
2016-06-27
0001450708
us-gaap:SubsequentEventMember
aurm:HumavoxMember
aurm:FirstInstallmentAmountMember
2016-06-01
2016-06-27
0001450708
2015-05-01
2015-07-31
0001450708
2014-05-01
2014-07-31
0001450708
2014-07-31
0001450708
us-gaap:CommonStockMember
aurm:AxisConsultantsPtyLtdMember
2014-11-01
2015-07-31
0001450708
aurm:GrantsIn2010Member
aurm:EquityIncentivePlan2010Member
2010-11-01
2011-10-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
10-Q
false
2015-07-31
2015
Q3
AURM
AURUM, INC.
0001450708
--10-31
Smaller Reporting Company
1076
12797
3073
2258
-1263541
13560
7794983
-9072084
-7502731
10560
2740207
-10253498
0.0001
0.0001
500000000
500000000
135600000
105600000
135600000
105600000
1181414
1181414
-397064
591987
-213415
0.01
-0.00
0.01
0.00
135600000
105600000
135850000
1079663
847163
232500
7257926
7025426
232500
13560
10560
<div><div><table id="zf84d42446a6a4b7696d3a704cb7a0000" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt '">(1)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: left; font: bold 10pt '">ORGANIZATION AND BUSINESS</div></td></tr></table></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000"> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">Aurum, Inc. ("Aurum” or the “Company") is a Delaware corporation, originally incorporated in Florida as Liquid Financial Engines, Inc. The principal stockholder of Aurum is Golden Target Pty Ltd., an Australian corporation (“Golden”), which owned 96.21% of Aurum as of January 31, 2015.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">On January 20, 2010, the Company re-incorporated in the state of Delaware (the “Reincorporation”) through a merger involving Liquid Financial Engines Inc. (“Liquid”) and Aurum, Inc., a Delaware Corporation that was a wholly owned subsidiary of Liquid. The Reincorporation was effected by merging Liquid with Aurum, with Aurum being the surviving entity. For financial reporting purposes Aurum is deemed a successor to Liquid.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">In July 2009, Golden acquired a 96% interest in Aurum from certain stockholders. In connection therewith, the Company appointed a new President/Chief Executive Officer and Chief Financial Officer/Secretary and a new sole Director. The sole director and stockholder of Golden is also the President of the Company.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">Commencing August 2009, the Company decided to focus on mineral exploration for gold and copper in the Lao Peoples Democratic Republic (Lao P.D.R or Laos).</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">In December 2010, the Company executed a Management and Shareholders Agreement with Argonaut Overseas Investments Ltd (“AOI”), an indirectly wholly owned Subsidiary of Argonaut Resources N.L., in respect to Argonaut’s 70% held Century Concession in Laos. The agreement appointed Aurum as the manager of the Century Thrust Joint Venture Agreement (“Joint Venture”) and the Company had the right to earn 72.86% of AOI’s interest in the Joint Venture which was equivalent to a 51% beneficial interest in the Century Concession.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Century Concession expired in fiscal 2014 and was not renewed. As a result, the Company no longer has any exploration interests in Laos.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company has now commenced a search for new projects that the Company may be able to acquire an interest in.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company’s ability to continue operations for the foreseeable future is dependent upon future funding from affiliated entities, capital raisings, or its ability to commence revenue producing operations and positive cash flows, however there can be no assurance that the Company will be successful in these efforts.</div></div>
0.7491
0.96
1.00
1.00
0.70
0.7286
0.51
86302
1206789
241650
2028-07-31
2033-07-31
827643
827643
827643
827643
96000000
9600000
30000000
250000
250000
9000
12000
2500000
750000
1/3 on December 13, 2010, 1/3 vested on November 17, 2011 and the balance vested on November 17, 2012.
The options vested 1/3 upon grant date, 1/3 vested on February 1, 2012 and the balance vested on February 1, 2013
2020-11-17
2018-02-01
0.81
2500000
1.00
1.00
1.00
3250000
2012
74397
15000000
7500000
0.30
0.10
0.40
16000000
5500000
0.50
P24M
2016-04-06
2016-07-29
38329
38329
7500000
100000
100000
2500000
0.22
2500000
2500000
0.22
2500000
184954
248841
184954
248841
1264617
7506767
1079663
7257926
1076
4036
-9072084
-10253498
7794983
2740207
105710000
105600000
105993000
105600000
1181414
-397064
591987
-213415
1208259
93181
580111
-79173
66646
57809
-93491
-490245
-45933
-134242
93491
490245
45933
134242
114
105
346036
104226
43737
111164
22610
17092
49640
33045
23218
12924
-89769
-252880
-63887
231275
-72
-963
-5595
423
-1997
-10539
1470
691
86302
241650
5057776
963
1076
4036
1076
4036
<div><div><table id="z36047f57623a4db28ab56f568e894360" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt '">(2)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: left; font: bold 10pt '">RECENT ACCOUNTING PRONOUNCEMENTS</div></td></tr></table></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000"> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company has implemented all new accounting pronouncements that are in effect and applicable to the Company. These pronouncements did not have any material impact on the consolidated financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">In June 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation”. The Company adopted the amendment to (Topic 915) Development Stage Entities, for the elimination of certain disclosures currently required under US GAAP in the consolidated financial statements for development stage entities. The amendment removes the definition of a development stage entity, thereby removing the financial reporting distinction between the development stage entities and reporting entities from US GAAP. The Company has eliminated the inception-to-date information in the statements of operations, cash flows, and stockholders’ equity (deficit). The consolidated financial statements are no longer labelled as an exploration or development stage entity, and no disclosure is required for a description of the development stage activities the entity is engaged or when they are no longer a development stage entity. This update also eliminates an exception provided to development stage entities in FASC Topic 810, Consolidation, for determining whether an entity is a Variable Interest Entity (VIE) based on the amount of equity at risk.</div></div>
<div><div><table id="z64fec89ab3c948c9845b6c5c61ceaae4" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt '">(3)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: left; font: bold 10pt '">GOING CONCERN</div></td></tr></table></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000"> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of Aurum as a going concern. Aurum has incurred net losses since inception and may continue to incur substantial and increasing losses for the next several years, all of which raises substantial doubt as to its ability to continue as a going concern.</div><div> </div><div style="text-align: justify; text-indent: 35.45pt; font: 10pt '">In addition, Aurum is reliant on loans and advances from corporations affiliated with the Company. Based on discussions with these affiliate companies, the Company believes this source of funding will continue to be available. Other than the arrangements noted above, the Company has not confirmed any other arrangements for ongoing funding. As a result the Company may be required to raise funds by additional debt or equity offerings in order to meet its cash flow requirements during the forthcoming year. However, there can be no assurance that the Company’s fund raising efforts will be successful.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The retained deficit of the Company at July 31, 2015 amounted to approximately $9,100,000.</div></div>
<div><div><table id="z001a624c0aa7456cb9845028bae6b229" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt '">(4)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: left; font: bold 10pt '">AFFILIATE TRANSACTIONS</div></td></tr></table></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000"> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company entered into an agreement with AXIS Consultants Pty Ltd (“AXIS”) to provide management and administration services to the Company. AXIS is affiliated through common management. The Company is one of nine affiliated companies to which AXIS provides services. Each of the companies has some common Directors, officers and shareholders. Currently, there are no material arrangements or planned transactions between the Company and any of the affiliated companies other than AXIS.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt '">During the nine months ended July 31, 2015, AXIS provided services in accordance with the services agreement, incurred direct costs on behalf of the Company and provided funding of $74,397. During the nine months ended July 31, 2015, the foreign exchange effect on the amounts owed to affiliates was a gain of $1,206,789. On July 31, 2015 the Company issued 30,000,000 shares of common stock to AXIS in satisfaction of a debt of $5,057,776. The amounts owed to affiliates as of July 31, 2015 and October 31, 2014 is $847,163 and $7,025,426, respectively, and are reflected in non-current liabilities - advances from affiliates. At July 31, 2015, the Company owed the former Managing Director of its Laos operation $232,500 (2014: $232,500). During the nine months ended July 31, 2015 and 2014, the affiliates have agreed not to charge interest.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company intends to repay these amounts with funds raised either via additional debt or equity offerings. Both affiliates have agreed not to call the advance within the next twelve months and accordingly the Company has classified the amounts payable as non-current in the accompanying balance sheet.</div></div>
<div><div><table id="zc36cb67e2ebc49fb8047f45f810118f6" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt '">(5)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: left; font: bold 10pt '">INCOME TAXES</div></td></tr></table></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000"> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">Aurum files its income tax returns on an accrual basis.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company follows the accounting requirements associated with uncertainty in income taxes using the provisions of FASB ASC 740, Income Taxes. Using that guidance, tax positions initially need to be recognized in the consolidated financial statements when it is more-likely-than-not the positions will be sustained upon examination by the tax authorities. It also provides guidance for de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of July 31, 2015, the Company has no uncertain tax positions that qualify for either recognition or disclosure in the consolidated financial statements.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company is required to file tax returns in the United States and a summary of the deferred tax asset at July 31, 2015 is as follows:</div><div> </div><table id="zec5f6f341d2c4baea44787c98d97eea8" border="0" cellspacing="0" cellpadding="0" align="left" style="width: 70%; font: 10pt '"><tr><td style="vertical-align: bottom; width: 70%; vertical-align: top"> </td><td colspan="3" style="vertical-align: bottom; vertical-align: top"><div style="text-align: right; font: 10pt '">USA</div><div style="text-align: right; font: 10pt '">$</div></td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td colspan="3" style="vertical-align: bottom; vertical-align: top"><div style="text-align: right; font: 10pt '">Total</div><div style="text-align: right; font: 10pt '">$</div></td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td></tr><tr><td style="vertical-align: bottom; width: 70%; vertical-align: top"><div style="text-align: left; font: 10pt '">Deferred tax assets</div></td><td colspan="3" style="vertical-align: bottom; vertical-align: top"> </td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td colspan="3" style="vertical-align: bottom; vertical-align: top"> </td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td></tr><tr><td style="vertical-align: bottom; width: 70%; vertical-align: top"> </td><td colspan="3" style="vertical-align: bottom; vertical-align: top"> </td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td colspan="3" style="vertical-align: bottom; vertical-align: top"> </td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td></tr><tr><td style="vertical-align: bottom; width: 70%; vertical-align: top"><div style="text-align: left; font: 10pt '">Net operating loss carry-forward</div></td><td style="vertical-align: bottom; text-align: right; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">827,643</div></td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; text-align: right; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">827,643</div></td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td></tr><tr><td style="vertical-align: bottom; padding-bottom: 2px; width: 70%; vertical-align: top"><div style="text-align: left; font: 10pt '">Less valuation allowance</div></td><td style="vertical-align: bottom; text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">(827,643</div></td><td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"><div style="font: 10pt '">)</div></td><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">(827,643</div></td><td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"><div style="font: 10pt '">)</div></td></tr><tr><td style="vertical-align: bottom; padding-bottom: 4px; width: 70%; vertical-align: top"><div style="text-align: left; font: 10pt '">Net deferred taxes</div></td><td style="vertical-align: bottom; text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">-</div></td><td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">-</div></td><td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td></tr></table><div style="clear: both"><br /></div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company has available net operating loss carry forwards as of October 31, 2014, which are subject to limitations, aggregating approximately $2,364,000 which would expire in years 2028 through 2034.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company’s tax returns for all years since fiscal 2012 remain open to examination by the respective tax authorities.  There are currently no tax examinations in progress.</div></div>
<div><div><table id="z973fa9c052b94cc9983f197122c722d5" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt '">(6)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: left; font: bold 10pt '">STOCKHOLDERS’ EQUITY</div></td></tr></table></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000"> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">In September 2008, 96,000,000 shares of common stock were issued to the Company’s founder raising $9,000.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">In March 2009, the Company raised $12,000 in a registered public offering of 9,600,000 shares of common stock share pursuant to a prospectus dated January 30, 2009.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">On July 31, 2015 the Company issued 30,000,000 shares of common stock to AXIS in satisfaction of a debt of $5,057,776.</div></div>
<div><div><table id="zb995b6a341fa44ec840b1d4d82bce854" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 28.5pt; vertical-align: top"><div style="text-align: left; font: bold 10pt ' color: #000000">(7)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: justify; font: bold 10pt ' color: #000000">ISSUE OF OPTIONS UNDER EQUITY INCENTIVE PLAN</div></td></tr></table></div><div> </div><div><table id="z0b7f3abc3a254b849b5a6babba236c3a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: 10pt ' color: #000000; margin-left: 18pt">(i)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: justify; font: 10pt ' color: #000000">Effective December 13, 2010, the Company issued 2,500,000 options over shares of Common Stock to employees under the 2010 Equity Incentive Plan that has been adopted by the Directors of the Company. The options vested 1/3 on December 13, 2010, 1/3 vested on November 17, 2011 and the balance vested on November 17, 2012. The exercise price of the options is US$1.00 and the latest exercise date for the options is November 17, 2020.</div></td></tr></table></div><div style="text-align: justify; font: 10pt ' color: #000000; margin-left: 36pt"> </div><div style="text-align: justify; font: 10pt ' color: #000000; margin-left: 36pt">The Company has accounted for all options issued based upon their fair value using the Binomial pricing model.</div><div> </div><div style="text-align: justify; text-indent: 0.55pt; font: 10pt ' color: #000000; margin-left: 35.45pt">At October 31, 2014, there were 2,500,000 options outstanding with an option price per share and weighted average exercise price of US$1.00.  The exercise price is US$1.00 per option. The weighted average per option fair value of options granted during fiscal 2011 was US$0.81.</div><div> </div><div style="text-align: justify; text-indent: 0.55pt; font: 10pt ' color: #000000; margin-left: 35.45pt"> As a result of the termination of the employee holding the options, the employee had a period of 90 days from the date of termination to exercise the options. The holder did not exercise the options therefore the options expired in May 2015.</div><div> </div><div><table id="z7accbfdc8a1e4ad085fec7734f900f8e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: 10pt ' color: #000000; margin-left: 18pt">(ii)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: justify; font: 10pt ' color: #000000">In May 2011, the Company issued 750,000 options over shares of Common Stock to employees under the 2010 Equity Incentive Plan that has been adopted by the Directors of the Company. The options vested 1/3 upon grant date, 1/3 vested on February 1, 2012 and the balance vested on February 1, 2013. The exercise price of the options is US$1.00 and the latest exercise date for the options is February 1, 2018.</div></td></tr></table></div><div style="text-align: justify; font: 10pt ' color: #000000; margin-left: 36pt"> </div><div style="text-align: justify; font: 10pt ' color: #000000; margin-left: 36pt">The Company has accounted for all options issued based upon their fair value using the Binomial pricing model.</div><div> </div><div style="text-align: justify; text-indent: 0.55pt; font: 10pt ' color: #000000; margin-left: 35.45pt">As a result of the termination of the employee holding the options, the employee had a period of 90 days from the date of termination to exercise the options. The holder did not exercise the options therefore the options have expired in April 2014.</div></div>
<div><div><table id="ze3d8e76c32434064ad341e91413a5d6c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt '">(8)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: left; font: bold 10pt '">FAIR VALUE OF FINANCIAL INSTRUMENTS</div></td></tr></table></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000"> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company’s financial instruments consist of cash, receivables, accounts payable, accrued expenses and advances from affiliates. The carrying amounts of cash, receivables, accounts payables and accrued expenses approximates their fair values because of the short term maturities of those instruments.  The fair value of the advances from affiliate is not determinable as it is due to an affiliated entity, no market exists for similar instruments and settlement date is uncertain.</div></div>
<div><div><table id="z7900320f5f74407ebfbb7cf464287e1f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt '">(9)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: left; font: bold 10pt '">NET INCOME ( LOSS) PER SHARE</div></td></tr></table></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000"> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">Basic income (loss) per share is computed by dividing net profit (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Options to acquire 3,250,000 shares of common stock were not included in the diluted weighted average shares outstanding as such effects would be anti-dilutive.</div></div>
<div><div><table id="z70457b75c4314a41b1c0e7fcf94ea5bd" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt '">(10)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: left; font: bold 10pt '">CASH</div></td></tr></table></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000"> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company maintains cash deposits with financial institutions in Australia and in Laos (USD).  Cash deposits maintained in Australian dollars are translated into US dollars at the period end exchange rate with the related adjustment recognized in statements of operations.</div></div>
<div><div><table id="z93ce1729241e4d4fab9d24481662de6e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt '">(11)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: left; font: bold 10pt '">SUBSEQUENT EVENTS</div></td></tr></table></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000"> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company has evaluated events and transactions after the balance sheet date and through the date the consolidated financial statements were issued, and believes that all relevant disclosures have been included herein and there are no other events which require recognition or disclosure in the accompanying interim consolidated financial statements.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">On April 1, 2016 the Company announced that it had entered into an agreement with an Israeli company, PayItSimple Ltd and its subsidiaries (PayItSimple) whereby the Company would invest $15 million directly into PayItSimple by September 5, 2016 to acquire a 30% interest in PayItSimple, and a further $7.5 million into PayItSimple over 18 months to acquire a further 10% interest in PayItSimple, taking its holding to 40% of interest in PayItSimple.  PayItSimple owns a business known as Splitit. On April 6, 2016 the Company terminated the proposed acquisition of PayItsimple.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">On June 27, 2016 the Company announced that it had entered into a binding term sheet with the shareholders of an Israeli company, Humavox Ltd (Humavox), a company that creates wireless charging solutions. In accordance with the proposed acquisition of Humavox, Aurum would acquire 100% of the shares of Humavox and 100% of the warrants and options to acquire shares of Humavox in exchange for the issue of shares of common stock of Aurum representing 50% of the shares of common stock of Aurum post issue on a fully-diluted basis, including the investment of an amount of US$16 million in Humavox.  The investment would take place in unconditional instalments over a period of 24 months following the closing. The closing of the merger was subject to certain closing conditions, including the investment in Humavox of the first instalment of the investment in the amount of $5.5 million. On July 29, 2016 the Company terminated the proposed acquisition of Humavox.</div><div> </div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">In April 2016, the Company raised $38,329 through the private placement of 250,000 shares of common stock.</div><div> </div><div style="text-align: left; text-indent: 36pt; font: 10pt '">On July 19, 2017, the Company entered into a Term Sheet with Lior Wayn, Erez Glazer and Dr Guy Shalom, (collectively, the ‘’Sellers”)  for the acquisition of all of the issued shares of a medical technology business. The Company has a 120 day period to conduct due diligence and negotiate a formal share sale agreement.</div><div> </div><div style="text-align: justify; text-indent: 72pt; font: 10pt '">The purchase price is up to USD$7,500,000 which is to be satisfied as follows:</div><div><br /></div><div><table id="z2fe2841907b54071aa86ce7994da282c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 72pt; vertical-align: top"><div style="text-align: left; font: 10pt ' margin-left: 54pt">a)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: justify; font: 10pt '">The sum of USD$100,000 payable to the Sellers for due diligence expenses, 30 business days from the execution of the Term Sheet;</div></td></tr></table></div><div> </div><div><br /></div><div><table id="z6083b984d1bd482e9a2a7431be49f50e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 72pt; vertical-align: top"><div style="text-align: left; font: 10pt ' margin-left: 54pt">b)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: justify; font: 10pt '"> A further USD$100,000 each month after the date in a) above for due diligence expenses, for 3 months,  payable to the Sellers for working capital purposes;</div></td></tr></table></div><div><br /></div><div><table id="zfe78d8ec4ace4bb095e2e55a41f92caf" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 72pt; vertical-align: top"><div style="text-align: left; font: 10pt ' margin-left: 54pt">c)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: justify; font: 10pt '">An issue of fully paid ordinary shares of common stock of the Company to the value of USD$2,500,000 (less any payments made to the Sellers under (a) and (b) above) to the Sellers at an issue price of USD$0.22 per share of common stock (Consideration Shares);</div></td></tr></table></div><div><br /></div><div><table id="z620fdc559770436cb0aa1685471f56b2" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 72pt; vertical-align: top"><div style="text-align: left; font: 10pt ' margin-left: 54pt">d)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: justify; font: 10pt '">The issue to the Sellers of shares of common stock to the equivalent to USD$2,500,000 at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$100,000 within twelve months after the first anniversary of Completion; and</div></td></tr></table></div><div><br /></div><div><table id="zb0d9c097a55440c68065e954233f52a5" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt '"><tr><td style="width: 72pt; vertical-align: top"><div style="text-align: left; font: 10pt ' margin-left: 54pt">e)</div></td><td style="width: auto; vertical-align: top"><div style="text-align: justify; font: 10pt '">The issue to the Sellers of shares of common stock to the equivalent to USD$2,500,000 at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$1,000,000 within twelve months after the first anniversary of Completion.</div></td></tr></table></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font: 10pt ' color: #000000">If the Transaction is terminated or is in the reasonable opinion of the Company unable to proceed at any point, the Vendors and the Sellers have agreed to convert any monies paid to the Sellers under (a) and (b) above into convertible securities in the Sellers.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font: 10pt ' color: #000000">As part of the agreement and as a condition to completion, the Company will raise USD$2,500,000.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font: 10pt ' color: #000000">Pending completion, the Sellers are required to carry on business in the ordinary course.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">In July 2017, the Company raised $38,329 through the private placement of 250,000 shares of common stock.</div></div>
<div><div style="text-align: justify; text-indent: 36pt; font: 10pt ' color: #000000">The Company is required to file tax returns in the United States and a summary of the deferred tax asset at July 31, 2015 is as follows:</div><div> </div><table id="zec5f6f341d2c4baea44787c98d97eea8" border="0" cellspacing="0" cellpadding="0" align="left" style="width: 70%; font: 10pt '"><tr><td style="vertical-align: bottom; width: 70%; vertical-align: top"> </td><td colspan="3" style="vertical-align: bottom; vertical-align: top"><div style="text-align: right; font: 10pt '">USA</div><div style="text-align: right; font: 10pt '">$</div></td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td colspan="3" style="vertical-align: bottom; vertical-align: top"><div style="text-align: right; font: 10pt '">Total</div><div style="text-align: right; font: 10pt '">$</div></td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td></tr><tr><td style="vertical-align: bottom; width: 70%; vertical-align: top"><div style="text-align: left; font: 10pt '">Deferred tax assets</div></td><td colspan="3" style="vertical-align: bottom; vertical-align: top"> </td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td colspan="3" style="vertical-align: bottom; vertical-align: top"> </td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td></tr><tr><td style="vertical-align: bottom; width: 70%; vertical-align: top"> </td><td colspan="3" style="vertical-align: bottom; vertical-align: top"> </td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td colspan="3" style="vertical-align: bottom; vertical-align: top"> </td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td></tr><tr><td style="vertical-align: bottom; width: 70%; vertical-align: top"><div style="text-align: left; font: 10pt '">Net operating loss carry-forward</div></td><td style="vertical-align: bottom; text-align: right; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">827,643</div></td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; text-align: right; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">827,643</div></td><td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td></tr><tr><td style="vertical-align: bottom; padding-bottom: 2px; width: 70%; vertical-align: top"><div style="text-align: left; font: 10pt '">Less valuation allowance</div></td><td style="vertical-align: bottom; text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">(827,643</div></td><td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"><div style="font: 10pt '">)</div></td><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">(827,643</div></td><td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"><div style="font: 10pt '">)</div></td></tr><tr><td style="vertical-align: bottom; padding-bottom: 4px; width: 70%; vertical-align: top"><div style="text-align: left; font: 10pt '">Net deferred taxes</div></td><td style="vertical-align: bottom; text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">-</div></td><td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td><td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 12%; vertical-align: bottom"><div style="font: 10pt '">-</div></td><td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td></tr></table></div>
2364000
P90D
P90D
5057776
3000
5054776
5057776
30000000